Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

寄眠症 (Parasomnias) 是一种精神疾病.

J D Parkes

    Lancet (London, England)
    |November 1, 1986
    PubMed
    概括
    此摘要是机器生成的。

    睡眠障碍,如睡眠行走和夜间恐怖症,是由于遗传,发育和环境影响而产生的. 虽然往往不需要治疗,但这些睡眠障碍偶尔会导致严重的伤害.

    科学领域:

    • 神经学 神经学
    • 睡眠医学 睡眠医学
    • 遗传学 是一个遗传学.

    背景情况:

    • 睡眠障碍包括一组睡眠障碍,其特点是睡眠期间的异常行为.
    • 了解麻病的病因包括考虑遗传倾向,发育阶段和环境触发因素的多因素组合.

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    A late haemorrhagic complication in an arteriovenous malformation cured with radiosurgery. Case report.

    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2012
    Same author

    The absorption and metabolism of a standard oral dose of levodopa in patients with Parkinsonism.

    British journal of clinical pharmacology·2012
    Same author

    Bromocriptine and dopamine receptor stimulation.

    British journal of clinical pharmacology·2012
    Same author

    Natural history, symptoms and treatment of the narcoleptic syndrome.

    Acta neurologica Scandinavica·2009
    Same author

    Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil.

    Journal of sleep research·1999
    Same author

    Genetic factors in human sleep disorders with special reference to Norrie disease, Prader-Willi syndrome and Moebius syndrome.

    Journal of sleep research·1999
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    查看所有相关文章